arrow
返回
D

David R. Bevan

university of science & technology of china, cas

53H指数
404论文数
1.0W被引数
收录论文 50
发表时间
Lambda-PCR for precise DNA assembly and modification
err2022-10-08
err3
errOAAI
errTanniche, Imen; Fisher, Amanda K.; Gillam, Frank; Collakova, Eva; Zhang, Chenming; Bevan, David R.; Senger, Ryan S.
err分享
err收藏
Biophysical insights into OR2T7: Investigation of a potential prognostic marker for glioblastoma
err2022-10-01
err3
errOAAI
errSharp, Amanda K.; Newman, David; Libonate, Gianna; Borns-Stern, Mary; Bevan, David R.; Brown, Anne M.; Anandakrishnan, Ramu
err分享
err收藏
Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues
err2022-06-29
err4
errOAAI
errPashikanti, Srinath; Foster, Daniel J.; Kharel, Yugesh; Brown, Anne M.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments
err2022-06-01
err7
errOAAI
errKawecki, Grant E.; King, Kelsie M.; Cramer, Nicholas A.; Bevan, David R.; Brown, Anne M.
err分享
err收藏
Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors
err2021-02-01
err5
errOAAI
errCongdon, Molly; Fritzemeier, Russell G.; Kharel, Yugesh; Brown, Anne M.; Serbulea, Vlad; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors
err2021-01-01
err12
errOAAI
errLi, Hao; Sibley, Christopher D.; Kharel, Yugesh; Huang, Tao; Brown, Anne M.; Wonilowicz, Laura G.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity
err2020-01-02
err15
errOAAI
errSibley, Christopher D.; Morris, Emily A.; Kharel, Yugesh; Brown, Anne M.; Huang, Tao; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
Insight into Amyloid Interactions: Molecular Dynamics Simulations of Model Peptide Fragments
err2019-02-01
err0
errOAAI
errCramer, Nicholas A.; Kawecki, Grant; Bevan, David R.; Brown, Anne M.
err分享
err收藏
Molecular Dynamics Simulations of gp120 and gp41 of HIV Env Provide Insights into Strain Specificity and the Role of the Membrane Environment
err2019-02-01
err0
errOAAI
errHollingsworth, Louis R.; Lemkul, Justin A.; Gandour, Richard D.; Bevan, David R.; Brown, Anne M.
err分享
err收藏
Natural product-based amyloid inhibitors
err2017-09-01
err172
errOAAI
errVelander, Paul; Wu, Ling; Henderson, Frances; Zhang, Shijun; Bevan, David R.; Xu, Bin
err分享
err收藏
Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity
err2017-04-25
err39
errOAAI
errChildress, Elizabeth S.; Kharel, Yugesh; Brown, Anne M.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
err分享
err收藏
err分享
err收藏
Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors
err2016-02-08
err24
errOAAI
errCongdon, Molly D.; Kharel, Yugesh; Brown, Anne M.; Lewis, Stephanie N.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.
err分享
err收藏
Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands
err2015-01-24
err11
errOAAI
errLewis, Stephanie N.; Garcia, Zulma; Hontecillas, Raquel; Bassaganya-Riera, Josep; Bevan, David R.
err分享
err收藏
Structural Basis of Phosphoinositide (PIP) Recognition by the TIRAP PIP-Binding Motif
err2015-01-01
err2
errOAAI
errZhao, Xiaolin; Xiao, Shuyan; Berk, Sam; Brown, Anne M.; Bevan, David R.; Armstrong, Geoffrey; Capelluto, Daniel G. S.
err分享
err收藏